Chapters

Transcript

Video

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease

Non-tuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), has become increasingly more prevalent in patients causing pulmonary dysfunction. Daniel Salerno, MD, is the principle investigator for a study designed to determine if clofazimine has anit-mycobacteral activity against MAC. In this video Dr. Salerno explains the study objectives, design as well as patient eligibility criteria, and how to enroll your patients who may be candidates.


Created by

Temple Health

Presenters

Daniel Salerno, MD, MS

Daniel Salerno, MD, MS

Associate Professor, Thoracic Medicine & Surgery, Lewis Katz School of Medicine at Temple University
Director, RICU (Critical Care Services), Temple University Hospital

Daniel A. Salerno, MD, MS is an Associate Professor, Thoracic Medicine & Surgery, Lewis Katz School of Medicine at Temple University and the Director, RICU (Critical Care Services) at Temple University Hospital. Dr. Salerno is board ...

View full profile